In rodent models of type 2 diabetes (T2D), sustained remission of hyperglycemia can be induced by a single intracerebroventricular (icv) injection of fibroblast growth factor 1 (FGF1), and the mediobasal hypothalamus (MBH) was recently implicated as the brain area responsible for this effect. To better understand the cellular response to FGF1 in the MBH, we sequenced >79,000 single-cell transcriptomes from the hypothalamus of diabetic Lepob/ob mice obtained on Days 1 and 5 after icv injection of either FGF1 or vehicle. A wide range of transcriptional responses to FGF1 was observed across diverse hypothalamic cell types, with glial cell types responding much more robustly than neurons at both time points. Tanycytes and ependymal cells were the most FGF1-responsive cell type at Day 1, but astrocytes and oligodendrocyte lineage cells subsequently became more responsive. Based on histochemical and ultrastructural evidence of enhanced cell-cell interactions between astrocytes and Agrp neurons (key components of the melanocortin system), we performed a series of studies showing that intact melanocortin signaling is required for the sustained antidiabetic action of FGF1. These data collectively suggest that hypothalamic glial cells are leading targets for the effects of FGF1 and that sustained diabetes remission is dependent on intact melanocortin signaling.
Nonalcoholic fatty liver disease (NAFLD) begins with benign steatosis caused by ectopic storage of triacylglycerols in the liver. Persistent steatosis, in combination with other genetic and environmental factors, leads to nonalcoholic steatohepatitis (NASH) characterized by functional impairment, inflammation, and fibrosis. However, it remains unclear how persistent steatosis directly contributes to the progression of NAFLD, which may represent a therapeutic target. The organ-on-a-chip (OOC) has emerged as a new culture platform to recapitulate human pathological conditions under which drug candidates can be screened. Here, we developed a simple OOC steatosis model using the Mimetas OrganoPlate with a human liver cell line, HepG2. Treating the HepG2 OOCs with fatty acid overload induced steatosis within 24 h. Moreover, persistent steatosis for 6 days impaired OOC viability and hepatic function, as measured by a WST-8 assay and albumin production, respectively. Lastly, the HepG2 OOCs were exposed to drugs being tested in clinical trials for NAFLD/NASH during the 6-day period. Pioglitazone improved the OOC viability while elafibranor reduced the steatosis in association with reduced viability and albumin production. In conclusion, we show that the HepG2 steatosis OOC model is a useful tool on which the efficacy and toxicity of various therapeutic candidates can be tested.
21 January 2023 in BMC Complementary Medicine and Therapies
Background: Capsaicinoids, such as dihydrocapsaicin (DHC), exert the health-promoting effects of chili peppers on energy metabolism. The metabolic responses to capsaicinoids are primarily mediated through transient receptor potential cation channel subfamily V member 1 (TRPV1). However, the varying contributions of their metabolites to beneficial health outcomes remain unclear. 8-methyl nonanoic acid (8-MNA), a methyl-branched medium chain fatty acid (MCFA), is an in vivo degradation by-product of DHC. Since MCFAs have emerged as metabolic modulators in adipocytes, here we examined various cellular responses to 8-MNA in 3T3-L1 adipocytes. Methods: The viability of 3T3-L1 adipocytes exposed to various concentrations of 8-MNA was assessed by the Calcein AM assay. Biochemical assays for lipid accumulation, AMP-activated protein kinase (AMPK) activity, lipolysis and glucose uptake were performed in 3T3-L1 adipocytes treated with 8-MNA during 48-h nutrient starvation or 5-day maturation. Results: 8-MNA caused no impact on cell viability. During nutrient starvation, 8-MNA decreased lipid amounts in association with AMPK activation, a molecular event that suppresses lipogenic processes. Moreover, 3T3-L1 adipocytes that were treated with 8-MNA during 5-day maturation exhibited a reduced lipolytic response to isoproterenol and an increased glucose uptake when stimulated with insulin. Conclusions: These results suggest that 8-MNA derived from DHC modulates energy metabolism in adipocytes and also support the idea that the metabolic benefits of chili consumption are partly attributable to 8-MNA.
1 January 2026 in American Journal of Physiology-Cell Physiology
Using a perfused 3-D human endothelium-on-a-chip, we investigated the endothelial glycocalyx (EGX) in vascular regulation. EGX degradation was linked to endothelial dysfunction induced by dengue NS1, but not by TNF-α. In HUVECs, heparan sulfate (HS) degradation increased permeability, whereas sialic acid (SA) cleavage had the opposite effect. SA degradation, but not HS, enhanced monocyte adhesion in HUVECs and human coronary ECs. This study highlights distinct, component-specific roles of HS and SA in regulating vascular function.
The WHO guideline recommends that the potential toxicity of herbs be comprehensively examined in preclinical settings prior to clinical evaluation. Organ-on-a-chip (OOC) technology has been suggested for this purpose because of its capacity to reflect human responses. While Lagerstroemia speciosa extracts have been used as treatment of diabetes, Lagerstroemia tomentosa extracts have not been well studied; however, their hepatotoxicity is largely unknown. Thus, we assessed the hepatotoxicity of Lagerstroemia extracts using a human liver OOC with HepG2 cells and this system’s efficacy compared to its 2D counterpart. Lagerstroemia speciosa extracts were prepared from fresh (LS) or shed (LSS) leaves, and Lagerstroemia tomentosa extracts were prepared from fresh leaves (LT). The OOCs exposed to the extracts at low concentrations for 24 h exhibited minimal viability reductions and were more sensitive to the toxicity of LS and LSS than the 2D cultures. Albumin production, a hepatic functional marker, in the OOCs was impaired by LS and LT, even at low concentrations. Seven-day exposure of the OOCs to LS further reduced viability and albumin production. This OOC study revealed the potential hepatotoxicity of Lagerstroemia extracts, suggesting that functional assessments of the liver may be required during clinical studies involving these extracts.
The WHO guideline recommends that the potential toxicity of herbs be comprehensively examined in preclinical settings before clinical evaluation. Organ-on-a-chip (OOC) technology has been suggested for this purpose because of its capacity to reflect human responses. While Lagerstroemia speciosa (L.) Martyn extracts have been used as treatment of diabetes, Lagerstroemia tomentosa C.Presl extracts have not been well studied; however, their hepatotoxicity is largely unknown. Thus, we assessed the hepatotoxicity of Lagerstroemia extracts using a human liver OOC with HepG2 cells and this system’s efficacy compared to its 2D counterpart. L. speciosa extracts were prepared from fresh (LS) or shed (LSS) leaves, and L. tomentosa extracts were prepared from fresh leaves (LT). The OOCs exposed to the extracts at medium-to-high concentrations for 24 h exhibited significant viability reductions and were more sensitive to the toxicity of LS and LSS than the 2D cultures. Albumin production, a hepatic functional marker, in the OOCs was impaired by LS and LT, even at low concentrations. Seven-day exposure of the OOCs to LS further reduced viability and albumin production. This OOC study revealed the potential hepatotoxicity of Lagerstroemia extracts, suggesting that functional assessments of the liver may be required during clinical studies involving these extracts.